Browse by author
Lookup NU author(s): Professor Roger Griffin
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Modulation of DNA repair pathways in oncology has been an area of intense interest in the last decade, not least as a consequence of the promising clinical activity of poly(ADP-ribose) polymerase ( PARP) inhibitors. In this review article, we highlight inhibitors of the phosphatidylinositol 3-kinase related kinase (PIKK) family as of potential interest in the treatment of cancer, both in combination with DNA-damaging therapies and as stand-alone agents. (C) 2012 Elsevier Ltd. All rights reserved.
Author(s): Finlay MRV, Griffin RJ
Publication type: Article
Publication status: Published
Journal: Bioorganic & Medicinal Chemistry Letters
Year: 2012
Volume: 22
Issue: 17
Pages: 5352-5359
Print publication date: 01/09/2012
ISSN (print): 0960-894X
ISSN (electronic): 1464-3405
Publisher: Pergamon
URL: http://dx.doi.org/10.1016/j.bmcl.2012.06.053
DOI: 10.1016/j.bmcl.2012.06.053
Altmetrics provided by Altmetric